BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 3966964)

  • 1. Pancreatic carcinogenesis-enhancement by cholecystokinin in the hamster-nitrosamine model.
    Howatson AG; Carter DC
    Br J Cancer; 1985 Jan; 51(1):107-14. PubMed ID: 3966964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic carcinogenesis: effect of secretin in the hamster- nitrosamine model.
    Howatson AG; Carter DC
    J Natl Cancer Inst; 1987 Jan; 78(1):101-5. PubMed ID: 3467121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cholecystokinin on pancreatic carcinogenesis in the hamster model.
    Pour PM; Lawson T; Helgeson S; Donnelly T; Stepan K
    Carcinogenesis; 1988 Apr; 9(4):597-601. PubMed ID: 2833367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of cholecystokinin in the development of BOP-induced pancreatic lesions in hamsters.
    Meijers M; van Garderen-Hoetmer A; Lamers CB; Rovati LC; Jansen JB; Woutersen RA
    Carcinogenesis; 1990 Dec; 11(12):2223-6. PubMed ID: 2265473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic cancer in the Syrian hamster induced by N-nitrosobis(2-oxopropyl)-amine: cocarcinogenic effect of epidermal growth factor.
    Chester JF; Gaissert HA; Ross JS; Malt RA
    Cancer Res; 1986 Jun; 46(6):2954-7. PubMed ID: 3009003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic carcinogenesis--the potential of cholecystokinin as a cocarcinogen in the hamster-nitrosamine model.
    Howatson AG
    Adv Exp Med Biol; 1986; 199():109-21. PubMed ID: 3799271
    [No Abstract]   [Full Text] [Related]  

  • 7. Pancreatic secretory abnormalities precede appearance of tumors of the pancreas in hamsters treated with bis-(2-oxopropyl)-N-nitrosamine.
    Rinderknecht H; Haberfelde G; Maset R; Collias K; Carmack C
    Dig Dis Sci; 1983 Jun; 28(6):526-38. PubMed ID: 6305606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effect of dibutyltin dichloride on pancreatic adenocarcinoma development by N-nitrosobis(2-oxopropyl)amine in the Syrian hamster.
    Jang JJ; Takahashi M; Furukawa F; Toyoda K; Hasegawa R; Sato H; Hayashi Y
    Jpn J Cancer Res; 1986 Nov; 77(11):1091-4. PubMed ID: 3098718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of high fat diet and cholecystokinin receptor blockade on pancreatic growth and tumor initiation in the hamster.
    Herrington MK; Permert J; Kazakoff KR; Pour PM; Zuker KA; Bilchik AJ; Adrian TE
    Carcinogenesis; 1993 May; 14(5):1021-6. PubMed ID: 7684953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promotional effects of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) on N-nitrosobis(2-oxopropyl)amine (BOP)-initiated carcinogenesis in hamsters.
    Furukawa F; Nishikawa A; Enami T; Mitsui M; Imazawa T; Tanakamaru Z; Kim HC; Lee IS; Kasahara K; Takahashi M
    Food Chem Toxicol; 1997; 35(3-4):387-92. PubMed ID: 9207901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Streptozotocin prevents development of nitrosamine-induced pancreatic cancer in the Syrian hamster.
    Bell RH; Strayer DS
    J Surg Oncol; 1983 Dec; 24(4):258-62. PubMed ID: 6228693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of octreotide, a somatostatin analogue, on initiation of pancreatic carcinogenesis in hamsters with N-nitrosobis(2-oxopropyl)amine.
    Furukawa F; Nishikawa A; Nakamura H; Miyauchi M; Son H; Hirose M
    Cancer Lett; 2000 Oct; 159(1):43-8. PubMed ID: 10974404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of raw soya diet and cholecystokinin receptor blockade on pancreatic growth and tumor initiation in the hamster.
    Herrington MK; Permert J; Kazakoff KR; Zucker KA; Bilchik AJ; Pour PM; Adrian TE
    Cancer Lett; 1994 Jul; 82(1):7-16. PubMed ID: 8033071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of bombesin on the development of N-nitrosobis(2-oxopropyl)amine-induced pancreatic lesions in hamsters.
    Meijers M; van Garderen-Hoetmer A; Lamers CB; Rovati LC; Jansen JB; Woutersen RA
    Cancer Lett; 1991 Jul; 59(1):45-50. PubMed ID: 1878860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A potent pancreatic carcinogen in Syrian hamsters: N-nitrosobis(2-oxopropyl)amine.
    Pour P; Althoff J; Krüger FW; Mohr U
    J Natl Cancer Inst; 1977 May; 58(5):1449-53. PubMed ID: 857032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholecystokinin inhibits DNA alkylation induced by N-nitrosobis (2-oxopropyl)amine (BOP) in hamster pancreas.
    Corra S; Kazakoff K; Lawson TA; Adrian TE; Pour PM
    Cancer Lett; 1992 Mar; 62(3):251-6. PubMed ID: 1596869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exocrine pancreatic secretion in the Syrian golden hamster Mesocricetus auratus--III. Effects of carcinogen administration and development of pancreas cancer.
    Helgeson AS; Lawson T; Pour P
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1984; 77(1):191-7. PubMed ID: 6141875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of streptozotocin diabetes on development of nitrosamine-induced pancreatic carcinoma when diabetes induction occurs after nitrosamine exposure.
    Povoski SP; Fenoglio-Preiser CM; Sayers HJ; McCullough PJ; Zhou W; Bell RH
    Carcinogenesis; 1993 May; 14(5):961-7. PubMed ID: 8504490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of crude soybean trypsin inhibitor on pancreatic ductal carcinogenesis in hamsters after initiation with N-nitrosobis(2-oxopropyl)amine.
    Furukawa F; Nishikawa A; Imaida K; Mitsui M; Enami T; Hayashi Y; Takahashi M
    Carcinogenesis; 1992 Nov; 13(11):2133-5. PubMed ID: 1330352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of biliary carcinogenesis in hamsters by cholecystokinin.
    Ikematsu Y; Tomioka T; Tajima Y; Tsunoda T; Kanematsu T
    World J Surg; 1995; 19(6):847-50; discussion 850-1. PubMed ID: 8553677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.